1 BACKGROUND Melanoma is a lethal skin cancer with heterogeneous clinical outcomes.1, 2 The American Joint Committee on Cancer guidelines currently stage melanoma from four factors: Breslow depth, ulceration, nodal spread and distant metastasis.3 Broadly, Stage I and II melanomas indicate localized disease with favourable prognosis,4 and exhibit relatively low risk of recurrence5 and disease-specific mortality.3 Despite this, early-stage melanomas contribute to a substantial proportion of...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jack
Contact Jack, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack